Summarized by Masters of Longevity from PR Newswire.
Aspirin-alone and reduced-dose NOAC-alone were noninferior to DAPT at six months.
Key Takeaways
- Aspirin alone was noninferior to DAPT for ischemic stroke prevention.
- Reduced-dose NOAC alone was noninferior to DAPT for ischemic stroke.
- Reduced-dose NOAC showed lower device-related thrombus versus DAPT.
